TY - JOUR
T1 - The Prognostic Value of Residual Coronary Stenoses after Functionally Complete Revascularization
AU - FAME Study Investigators
AU - Kobayashi, Yuhei
AU - Nam, Chang Wook
AU - Tonino, Pim A.L.
AU - Kimura, Takumi
AU - De Bruyne, Bernard
AU - Pijls, Nico H.J.
AU - Fearon, William F.
N1 - Funding Information:
St. Jude Medical sponsored the FAME study. Dr. Kobayashi has received an institutional research fellowship grant from Boston Scientific. Dr. De Bruyne is a consultant for St. Jude Medical, Opsens, and Boston Scientific; and receives institutional research support from Abbott, Medtronic, St. Jude Medical, and Boston Scientific. Dr. Pijls is a consultant for St. Jude Medical and Opsens; and receives institutional research support from Medtronic. Dr. Fearon receives institutional research grants from St. Jude Medical and Medtronic; and is a consultant for Medtronic and HeartFlow. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2016 American College of Cardiology Foundation.
PY - 2016/4/12
Y1 - 2016/4/12
N2 - Background The residual SYNTAX score (RSS) and SYNTAX revascularization index (SRI) quantitatively assess angiographic completeness of revascularization for patients with multivessel coronary artery disease. Whether residual angiographic disease remains of prognostic importance after "functionally" complete revascularization with fractional flow reserve (FFR) guidance is unknown. Objectives This study sought to investigate the prognostic value of the RSS and SRI after FFR-guided functionally complete revascularization. Methods From the FFR-guided percutaneous coronary intervention (PCI) cohort of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) trial, the RSS and SRI were calculated in 427 patients after functionally complete revascularization. The RSS was defined as the SYNTAX score (SS) recalculated after PCI. The SRI was calculated as: 100 × (1 - RSS/baseline SS) (%). We compared differences in 1- and 2-year outcomes among patients with RSS of 0, >0 to 4, >4 to 8, and >8, and with SRI of 100%, 50% to <100%, and 0 to <50%. Results The mean baseline SS, RSS, and SRI were 14.4 ± 7.2, 6.5 ± 5.8, and 55.1 ± 32.5%, respectively. Major adverse cardiac events (MACE) at 1 year occurred in 53 patients (12.4%). Patients with MACE had higher SS than those without (18.0 [interquartile range (IQR): 11.0 to 21.0] vs. 12.0 [IQR: 9.0 to 18.0], p = 0.001), but had similar RSS and SRI after PCI (RSS: 6.0 [IQR: 3.0 to 10.0] vs. 5.0 [IQR: 2.0 to 9.5], p = 0.51 and SRI: 60.0% [IQR: 40.9% to 78.9%] vs. 58.8% [IQR: 26.7% to 81.8%], p = 0.24, respectively). Kaplan-Meier analysis showed similar 1-year incidence of MACE with RSS/SRI stratifications (log-rank p = 0.55 and p = 0.54, respectively). Results were similar with 2-year outcome data analysis. Conclusions After functionally complete revascularization with FFR guidance, residual angiographic lesions that are not functionally significant do not reflect residual ischemia or predict a worse outcome, supporting functionally complete, rather than angiographically complete, revascularization.
AB - Background The residual SYNTAX score (RSS) and SYNTAX revascularization index (SRI) quantitatively assess angiographic completeness of revascularization for patients with multivessel coronary artery disease. Whether residual angiographic disease remains of prognostic importance after "functionally" complete revascularization with fractional flow reserve (FFR) guidance is unknown. Objectives This study sought to investigate the prognostic value of the RSS and SRI after FFR-guided functionally complete revascularization. Methods From the FFR-guided percutaneous coronary intervention (PCI) cohort of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) trial, the RSS and SRI were calculated in 427 patients after functionally complete revascularization. The RSS was defined as the SYNTAX score (SS) recalculated after PCI. The SRI was calculated as: 100 × (1 - RSS/baseline SS) (%). We compared differences in 1- and 2-year outcomes among patients with RSS of 0, >0 to 4, >4 to 8, and >8, and with SRI of 100%, 50% to <100%, and 0 to <50%. Results The mean baseline SS, RSS, and SRI were 14.4 ± 7.2, 6.5 ± 5.8, and 55.1 ± 32.5%, respectively. Major adverse cardiac events (MACE) at 1 year occurred in 53 patients (12.4%). Patients with MACE had higher SS than those without (18.0 [interquartile range (IQR): 11.0 to 21.0] vs. 12.0 [IQR: 9.0 to 18.0], p = 0.001), but had similar RSS and SRI after PCI (RSS: 6.0 [IQR: 3.0 to 10.0] vs. 5.0 [IQR: 2.0 to 9.5], p = 0.51 and SRI: 60.0% [IQR: 40.9% to 78.9%] vs. 58.8% [IQR: 26.7% to 81.8%], p = 0.24, respectively). Kaplan-Meier analysis showed similar 1-year incidence of MACE with RSS/SRI stratifications (log-rank p = 0.55 and p = 0.54, respectively). Results were similar with 2-year outcome data analysis. Conclusions After functionally complete revascularization with FFR guidance, residual angiographic lesions that are not functionally significant do not reflect residual ischemia or predict a worse outcome, supporting functionally complete, rather than angiographically complete, revascularization.
KW - SYNTAX revascularization index
KW - fractional flow reserve
KW - multivessel revascularization
KW - residual SYNTAX score
UR - http://www.scopus.com/inward/record.url?scp=84962169087&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84962169087&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2016.01.056
DO - 10.1016/j.jacc.2016.01.056
M3 - Article
C2 - 27056776
AN - SCOPUS:84962169087
SN - 0735-1097
VL - 67
SP - 1701
EP - 1711
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 14
ER -